UniSuper Management Pty Ltd Grows Stock Position in Agilent Technologies, Inc. $A

UniSuper Management Pty Ltd raised its position in Agilent Technologies, Inc. (NYSE:A) by 26.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,822 shares of the medical research company’s stock after buying an additional 7,157 shares during the quarter. UniSuper Management Pty Ltd’s holdings in Agilent Technologies were worth $4,341,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in A. Vanguard Group Inc. raised its stake in Agilent Technologies by 1.8% in the 2nd quarter. Vanguard Group Inc. now owns 33,997,845 shares of the medical research company’s stock valued at $4,012,086,000 after acquiring an additional 589,219 shares during the period. Massachusetts Financial Services Co. MA increased its stake in shares of Agilent Technologies by 10.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock worth $1,560,964,000 after purchasing an additional 1,273,994 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Agilent Technologies by 1.6% in the second quarter. Geode Capital Management LLC now owns 7,319,530 shares of the medical research company’s stock valued at $860,137,000 after purchasing an additional 115,183 shares during the period. Generation Investment Management LLP raised its position in shares of Agilent Technologies by 15.9% in the second quarter. Generation Investment Management LLP now owns 5,775,860 shares of the medical research company’s stock valued at $681,609,000 after purchasing an additional 792,304 shares during the period. Finally, Norges Bank purchased a new stake in shares of Agilent Technologies during the 2nd quarter valued at approximately $395,088,000.

Insider Buying and Selling

In other news, CEO Padraig Mcdonnell sold 12,490 shares of Agilent Technologies stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the completion of the sale, the chief executive officer directly owned 33,448 shares of the company’s stock, valued at approximately $5,017,200. The trade was a 27.19% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the transaction, the vice president owned 31,846 shares of the company’s stock, valued at $4,935,811.54. This trade represents a 8.61% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 16,401 shares of company stock valued at $2,468,962.

Agilent Technologies Price Performance

NYSE:A opened at $134.90 on Monday. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $160.27. The stock has a fifty day moving average of $143.36 and a 200 day moving average of $134.14. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96. The firm has a market capitalization of $38.25 billion, a price-to-earnings ratio of 29.52, a P/E/G ratio of 3.92 and a beta of 1.29.

Agilent Technologies (NYSE:A) last announced its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. The business had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.83 billion. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The company’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.46 EPS. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, research analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be given a dividend of $0.255 per share. The ex-dividend date is Tuesday, January 6th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 annualized dividend and a yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.32%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. The Goldman Sachs Group initiated coverage on shares of Agilent Technologies in a report on Tuesday, December 9th. They set a “buy” rating and a $170.00 target price on the stock. Morgan Stanley initiated coverage on Agilent Technologies in a research report on Tuesday, December 2nd. They issued an “overweight” rating for the company. Rothschild & Co Redburn assumed coverage on Agilent Technologies in a research note on Wednesday, October 8th. They set a “buy” rating and a $165.00 price objective on the stock. Hsbc Global Res upgraded Agilent Technologies to a “strong-buy” rating in a research note on Tuesday, January 20th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Agilent Technologies in a report on Monday, December 29th. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $164.50.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.